Scholarly Index
J. Carl Barrett
AstraZeneca (United States); 38,529 total citations; 396 total publications; best world rank #67
AstraZeneca (United States)
38,529Total citations
396Total publications
85H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Genomics and Diagnostics | Lifetime | 405 | US 234 | 99.23 |
| Telomeres, Telomerase, and Senescence | Lifetime | 67 | US 40 | 98.06 |
| Carcinogens and Genotoxicity Assessment | Lifetime | 275 | US 142 | 98.38 |
| DNA Repair Mechanisms | Lifetime | 503 | US 282 | 97.80 |
| Molecular Biology Techniques and Applications | Lifetime | 476 | US 243 | 96.60 |
| Cancer-related Molecular Pathways | Lifetime | 709 | US 376 | 97.66 |
| Animal Genetics and Reproduction | Lifetime | 713 | US 329 | 95.93 |
| PARP inhibition in cancer therapy | Lifetime | 625 | US 281 | 93.46 |
| Coagulation and Flocculation Studies | Lifetime | 527 | US 104 | 85.14 |
| PARP inhibition in cancer therapy | 2021-2025 | 434 | US 168 | 88.12 |